Faiz Ullah Khan | Pharmacology Toxicology and Pharmaceutical Science | Editorial Board Member

Published on by Young Scientists Awards

Dr. Faiz Ullah Khan | Pharmacology Toxicology and Pharmaceutical Science
| Editorial Board Member

Peking University | China

Dr. Faiz Ullah Khan is a pharmacy researcher and academic specializing in clinical pharmacy, pharmacy administration, antimicrobial stewardship, and public health pharmacy. He is currently engaged in postdoctoral research focusing on antibiotic use, resistance, and optimized therapeutic interventions. His academic journey includes a PhD in Pharmacy Administration and Clinical Pharmacy, with prior training in pharmacy practice and clinical pharmacology across leading institutions in Asia and Europe.Dr. Khan has previously served in various academic and research roles, including Assistant Professor and Head of a Clinical Pharmacy Section, senior lecturer positions, and research fellowships. His doctoral work emphasized antibiotic adherence, stewardship programs, and mixed-methods research design, contributing significantly to the understanding of antibiotic misuse and public health challenges in low- and middle-income settings. He has authored numerous peer-reviewed publications across reputable international journals, covering topics such as antimicrobial resistance, clinical interventions, pharmacovigilance, vaccine acceptance, and quality-of-life assessments. In addition, he has contributed multiple book chapters focusing on medication safety, public health education, and pharmacist-led care. Dr. Khan is frequently invited as a guest speaker at international conferences and forums and actively contributes as a reviewer and guest editor for various scientific journals. His professional interests also extend to mentoring postgraduate and undergraduate students, leading academic initiatives, and promoting safe and rational medicine use through research, teaching, and community engagement.

Featured Publications

Muhammad, K., Saqlain, M., Muhammad, G., Hamdard, A., Naveed, M., Butt, M. H., … Khan, F. U. (2022)
Knowledge, attitude, and practices (KAPs) of community pharmacists regarding COVID-19: A cross-sectional survey in two provinces of Pakistan. Disaster Medicine and Public Health Preparedness, 16(5), 1864–1872.
https://doi.org/10.1017/dmp.2021.17 (If a DOI exists—this is the correct DOI for the article.)

Khan, F. U., Khan, F. U., Hayat, K., Chang, J., Saeed, A., Khan, Z., Ashraf, M., … Fang, Y. (2020)
Knowledge, attitude, and practices among consumers toward antibiotic use and antibiotic resistance in Swat, Khyber-Pakhtunkhwa, Pakistan. Expert Review of Anti-Infective Therapy, 18(9), 937–946.
https://doi.org/10.1080/14787210.2020.1769477

 Khan, F. U., Khan, F. U., Hayat, K., Ahmad, T., Khan, A., Chang, J., Malik, U. R., … Fang, Y. (2021).
Knowledge, attitude, and practice on antibiotics and its resistance: A two-phase mixed-methods online study among Pakistani community pharmacists to promote rational antibiotic use. International Journal of Environmental Research and Public Health, 18(3), 1320.
https://doi.org/10.3390/ijerph18031320

Dharmalingam Kirubakaran | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Dr. Dharmalingam Kirubakaran l Pharmacology
| Young Scientist Award

Saveetha University | India

Dr. Dharmalingam Kirubakaran’s research focuses on the green synthesis of nanoparticles and their multifaceted biomedical applications, encompassing antioxidant, antibacterial, anti-inflammatory, antidiabetic, and anticancer activities. His work extensively explores plant-mediated nanoparticle synthesis using bioactive extracts from species such as Strobilanthes cordifolia, Acmella caulirhiza, Cajanus albicans, Lantana camara, and Mangifera indica, combining traditional phytochemistry with advanced nanotechnology approaches. Characterization techniques employed include UV-Visible spectrophotometry, Fourier Transform Infrared (FTIR) spectroscopy, X-ray Diffraction (XRD), Scanning and Transmission Electron Microscopy (SEM/TEM), Energy Dispersive Spectroscopy (EDAX), and Dynamic Light Scattering (DLS), ensuring comprehensive analysis of particle morphology, size, and stability. Complementing synthesis studies, his in vitro assessments encompass antibacterial activity against Gram-positive and Gram-negative bacteria, antioxidant assays such as DPPH, ABTS, H₂O₂, and FRAP, anti-inflammatory and antidiabetic evaluations, anticholinergic enzyme inhibition, and anticancer effects on multiple cell lines including MCF-7, A431, HeLa, and A549. Additional investigations include mosquito larvicidal bioassays, photocatalytic dye degradation, and ethnobotanical studies of medicinal plants. His publications reveal a strong emphasis on sustainable, plant-based nanomaterials for biomedical applications, with work on PVA–PEG and chitosan-based nanocomposites highlighting potential in food packaging, therapeutic interventions, and drug delivery. Collectively, his research integrates phytochemistry, nanotechnology, and pharmacological evaluation to advance environmentally friendly and biologically effective solutions for healthcare and environmental challenges.

Featured Publications

  • Kirubakaran, D., Wahid, J. B. A., Karmegam, N., Jeevika, R., Sellapillai, L., … (2025). A comprehensive review on the green synthesis of nanoparticles: Advancements in biomedical and environmental applications. Biomedical Materials & Devices, 1–26.

  • Manimegalai, P., Selvam, K., Loganathan, S., Kirubakaran, D., Shivakumar, M. S., … (2024). Green synthesis of zinc oxide (ZnO) nanoparticles using aqueous leaf extract of Hardwickia binata: Their characterizations and biological applications. Biomass Conversion and Biorefinery, 14(11), 12559–12574.

  • Kirubakaran, D., Selvam, K., Prakash, P., Shivakumar, M. S., Rajkumar, M. (2023). In-vitro antioxidant, antidiabetic, anticholinergic activity of iron/copper nanoparticles synthesized using Strobilanthes cordifolia leaf extract. OpenNano, 14, 100188.

  • Rajkumar, M., Presley, S. I. D., Govindaraj, P., Kirubakaran, D., Farahim, F., Ali, T., … (2025). Synthesis of chitosan/PVA/copper oxide nanocomposite using Anacardium occidentale extract and evaluating its antioxidant, antibacterial, anti-inflammatory and … Scientific Reports, 15(1), 3931.

  • Kirubakaran, D., Bupesh, G., Wahid, J. B. A., Murugeswaran, R., Ramalingam, J., … (2025). Green synthesis of zinc oxide nanoparticles using Acmella caulirhiza leaf extract: Characterization and assessment of antibacterial, antioxidant, anti … Biomedical Materials & Devices, 1–22.

Surapon Nochaiwong | Pharmacoepidemiology | Best Researcher Award

Published on by Young Scientists Awards

Mr.Surapon Nochaiwong | Pharmacoepidemiology | Best Researcher Award

 

👨‍🏫 🌾🌟Mr. Surapon Nochaiwong, a distinguished figure in pharmacoepidemiology and clinical epidemiology, serves as an academic staff member in the Department of Pharmaceutical Care at Chiang Mai University, Thailand. 🎓 Holding a Doctor of Pharmacy (Pharm.D.) degree, he is also the founding Vice Head of the Pharmacoepidemiology and Statistics Research Center (PESRC) at the Faculty of Pharmacy.Nochaiwong’s educational journey includes a Pharm.D. from Chiang Mai University, a General Residency in Pharmacotherapy, and diplomas in Clinical Statistics and Clinical Epidemiology. His commitment to education and research makes him a respected figure in the academic and scientific community. 🔬🎓

 

🌐 Professional Profiles

Affiliation/Community 🏛️

Pharmacoepidemiology and Statistics Research Center (PESRC) Faculty of Pharmacy, Chiang Mai University 50200 Department of Pharmaceutical Care Faculty of Pharmacy, Chiang Mai University 50200

Personal Statement 🌟

Surapon Nochaiwong earned his Doctor of Pharmacy (Pharm.D.) degree from Chiang Mai University, Thailand. Currently holding an academic position in the Department of Pharmaceutical Care, Faculty of Pharmacy, he is also the founding Vice Head of the Pharmacoepidemiology and Statistics Research Center (PESRC) at Chiang Mai University.

Since joining the Faculty of Pharmacy in 2012, Nochaiwong has actively contributed as a young scientist and principal investigator on over 10 extramurally funded local and national grants. He has an impressive publication record with more than 50 manuscripts and conference abstracts, accumulating over 800 citations in the international scientific community. His research interests span clinical epidemiology, pharmacoepidemiology, patient-reported outcomes in dialysis patients, and systematic review & evidence-based synthesis in nephrology and dermatology.

Areas of Expertise/Knowledge 🧠

Clinical Epidemiology, Pharmacoepidemiology, Dialysis, Chronic Pruritus, Patient-Reported Outcomes, Systematic Review and Knowledge Synthesis, Mental Health and COVID-19

Positions and Honors 🏆

2021 – Present: Co-principal investigator, Government of Canada, the Canadian Institutes of Health Research (CIHR) Operating Grant: Emerging COVID-19 Research Gaps & Priorities, 2020 – Present: Principal investigator and head of the HOME-COVID-19 consortium, 2016 – Present: Head of the Pharmacoepidemiology and Statistics Research Center (PESRC), 2017 – Present: Head of the Thai Renal Outcomes Research (THOR) Investigators, 2019 – Present: Vice head of the Evidence-Based Synthesis in Dermatology (EBSD), 2015 – 2017: Co-principal investigator, Funded by Health Systems Research Institute of Thailand (HSRI) through National Research Council of Thailand (NRCT), 2013 – 2014: Principal investigator, Young Researcher Granted by Chiang Mai University

Education 📚

Doctor of Pharmacy (Pharm.D.), Faculty of Pharmacy, Chiang Mai University, Thailand, General Residency in Pharmacotherapy, The College of Pharmacotherapy of Thailand, Thailand,  Diploma in Clinical Statistics, Faculty of Medicine, Chiang Mai University, Thailand Diploma in Clinical Epidemiology, Faculty of Medicine, Chiang Mai University, Thailand

Work Experience 👨‍💼

2012-Present: Faculty of Pharmacy, Chiang Mai University, Thailand This detailed information provides a comprehensive overview of Surapon Nochaiwong’s academic and research journey, along with his significant contributions and affiliations in the field of pharmacy and healthcare.

📚Top Noted Publication

Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Clinical Outcomes, Patient-Reported Outcomes, and Economic Burden for Thai People Living with Chronic Urticaria (CORE-CU) in routine practice: A study protocol for a monocentric prospective longitudinal study

Transcultural adaptation and psychometric validation of the Thai-Brief Resilient Coping Scale: a cross-sectional study during the coronavirus disease 2019 pandemic in Thailand

Service-level barriers to and facilitators of access to services for the treatment of alcohol use disorder and problematic alcohol use: protocol for a scoping review

Psychological Resilience and Adverse Mental Health Issues in the Thai Population during the Coronavirus Disease 2019 Pandemic

Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives

Pharmacological interventions for hidradenitis suppurativa: a protocol for systematic review and network meta-analysis of randomised trials and non-randomised studies

Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study

Disparities and Factors Associated with Coronavirus Disease-2019-Related Public Stigma: A Cross-Sectional Study in Thailand

Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis